A randomised, double-blind, placebo-controlled study to evaluate the efficacy of imiquimod 5% in women with vulvar intraepithelial neoplasia (VIN) stages two and three

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2006
This article has no abstract
Epistemonikos ID: a87b77f1679c9c22820eb6f5b5a6fc4ded3dff85
First added on: Jan 16, 2025